文献速递肿瘤 PET/CT骨显像与常规 SPECT

一例男性转移性乳腺癌患者的18F-PSMA 1007摄取

18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer.
PubMed 文献 · Clin Nucl Med · 2020-01-01

一名72岁男性转移性乳腺癌患者因临床怀疑同步前列腺癌而行18F-PSMA 1007 PET/CT,前列腺内未见异常摄取灶,但左乳软组织病灶、转移淋巴结及骨骼病灶可见异常摄取,且较18F-FDG PET/CT检出更多骨病灶。本例提示18F-PSMA 1007或可用于男性转移性乳腺癌的显像。

要点

  • 18F-PSMA 1007 PET/CT在前列腺内未见异常摄取灶。
  • 左乳软组织病灶、转移淋巴结及骨骼病灶可见异常摄取。
  • 较18F-FDG PET/CT,18F-PSMA 1007检出更多骨病灶。

核心结论

  • 本例发现提示18F-PSMA 1007或可用于男性转移性乳腺癌的显像。

研究设计与样本

  • 本文为个案报告,对象为一名72岁已知转移性乳腺癌的男性患者。

主要发现

  • 18F-PSMA 1007 PET/CT示前列腺内无异常摄取灶,左乳软组织病灶、转移淋巴结及骨骼病灶可见异常摄取。
  • 与18F-FDG PET/CT相比,18F-PSMA 1007显像检出更多骨病灶。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 72-year-old man, who is known with a case of metastatic carcinoma of the breast, was referred for F-PMSA 1007 PET/CT with clinical suspicion of synchronous prostate cancer. F-PSMA 1007 PET/CT scan detected no abnormal tracer concentrating lesion in the prostate gland; however, abnormal tracer concentration was noted in soft tissue lesions in left breast, metastatic lymph nodes, and skeletal lesions. Compared with F-FDG PET/CT, more bone lesions were detected on F-PSMA 1007 imaging. The findings of our case open the possibility of imaging metastatic breast cancer with F-PSMA 1007 in men.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Marafi F, Sasikumar A, Alfeeli M, et al. 18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer. Clin Nucl Med. 2020. PMID: 32332302. doi:10.1097/RLU.0000000000003013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。